AlphaMark Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-750
| Closed | -$12K | – | 809 |
|
|
2024
Q2 | $12K | Hold |
750
| – | – | ﹤0.01% | 510 |
|
|
2024
Q1 | $11K | Hold |
750
| – | – | ﹤0.01% | 524 |
|
|
2023
Q4 | $8K | Hold |
750
| – | – | ﹤0.01% | 555 |
|
|
2023
Q3 | $8K | Hold |
750
| – | – | ﹤0.01% | 544 |
|
|
2023
Q2 | $6K | Hold |
750
| – | – | ﹤0.01% | 475 |
|
|
2023
Q1 | $7K | Hold |
750
| – | – | ﹤0.01% | 466 |
|
|
2022
Q4 | $7K | Hold |
750
| – | – | ﹤0.01% | 430 |
|
|
2022
Q3 | $6K | Hold |
750
| – | – | ﹤0.01% | 484 |
|
|
2022
Q2 | $6K | Hold |
750
| – | – | ﹤0.01% | 453 |
|
|
2022
Q1 | $7K | Hold |
750
| – | – | ﹤0.01% | 441 |
|
|
2021
Q4 | $6K | Buy |
+750
| New | +$6K | ﹤0.01% | 440 |
|
|
2019
Q1 | – | Sell |
-1,575
| Closed | -$24K | – | 514 |
|
|
2018
Q4 | $24K | Buy |
+1,575
| New | +$24K | 0.01% | 236 |
|